Stephen Okoro

19 w - Tradurre

HIV-prevention inj+ction, which costs just $28,000 per person per year in the U.S., begins its first public rollout in Africa
South Africa, Eswatini and Zambia on Monday began administering a revolutionary HIV-prevention inj+ction, marking the first public rollout of the dr*g in Africa the region with the highest HIV burden globally. The twice-yearly inj+ction, known as lenacapavir, has demonstrated more than 99.9 percent efficacy in reducing HIV transmission, making it one of the most powerful prevention tools yet developed.